Clinical Trial Update: Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL Admixed With Bupi vs. Bupi Only Administered as Combined Sciatic and Adductor Canal Nerve Block for Postsurgical Analgesia in Lower Extremity Surgeries [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating EXPAREL with bupivacaine for postoperative analgesia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bunion
• Forefoot Surgery
• Hindfoot Fusion
• Metatarsophalangeal Fusion
• Midfoot Fusion
• Total Ankle Arthroplasty

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Bunion, Metatarsophalangeal Fusion | Phase 3 | Status: WITHDRAWN